New Oral Agent Shows Clinical Activity in Rare C3 Glomerulopathy New Oral Agent Shows Clinical Activity in Rare C3 Glomerulopathy
A new oral complement inhibitor showed clinically meaningful activity, compared with placebo, in a rare kidney disease.Medscape Medical News
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Nephrology News Source Type: news
More News: Kidney Transplant | Kidney Transplantation | Transplant Surgery | Transplants | Urology & Nephrology